The Nature of the Creutzfeldt-Jakob Disease

The nature of Creutzfeldt-Jakob disease dementia has traditionally been thought of as a possible outcome of aging. Their effects are painful, bringing great pain to the patient, their families, and their friends. There are many factors to consider. What is the best cure for my beloved person? Who will look after them. These are very difficult decisions affecting patients and their families over the next few years. But what happens if you have only a few months to make these decisions?

The disease was first described by German neurologist Hans Gerhard Kreuzfeld in 1920 and was immediately described by Alphonse Maria Jacob and named Creutzfeld Jakob. Some of the clinical findings described in their initial paper did not match the current criteria for Creutzfeldt-Jakob disease, which means that at least two patients of the first study had different diseases It is inferred. The early description of familial CJD is a German psychiatrist and neuroscientist Friedrich Meggendorfer (1880-1953) origin. Research published in 1997 counted cases of over 100 infectious CJDs worldwide as new cases continued to emerge

Familial Creutzfeldt-Jakob disease is caused by a specific change in chromosome 20 gene encoding the biological design of the prion protein. People with familial Creutzfeldt-Jakob disease do this because they inherit genetic variation from their parents. Familial Creutzfeldt-Jakob disease accounts for about 10% to 15% of cases. On average, it develops to a lesser extent than sporadic Creutzfeldt-Jakob disease, some of which occur at an early age of 20 to 40 years. Medical procedures include instruments for neurosurgical surgery, human-derived growth hormone, or certain transplanted human tissues. The use of improved sterilization technology, new disposable equipment and synthetic source of growth hormone greatly reduces the risk of Creutzfeldt-Jakob disease in medical procedures